FDA Inspection 1338640 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Sep 18, 2026 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lubbock, TX (United States)